Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis LamperticoPietro MaussStefan PersicoMarcello BarclayStephen T. MarxSteven LohmannKristina BondinMark ZhangZhenZhen MarraFiona BelperioPamela S. WedemeyerHeiner FlammSteven 2020 <p><strong>Article full text</strong></p><p><br>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).</p><p>© The authors, CC-BY-NC 2020.</p>